First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases

Go back to First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases
(NASDAQ: TRAX) Delayed: 17.64 +0.61 (3.58%)
Previous Close $17.03    52 Week High
Open $17.03    52 Week Low
Day High $17.97    P/E N/A 
Day Low $16.88    EPS
Volume 415,308